John Simard - Oct 7, 2021 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Queena Han under Power of Attorney for John Simard
Stock symbol: XBIT
Transactions as of: Oct 7, 2021
Transactions value $: -$1,131,099
Form type: 4
Date filed: 10/15/2021, 12:26 PM
Previous filing: Oct 6, 2021
Next filing: Feb 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XBIT	Common Stock	Sale	-$489K	-39.3K	-0.99%	$12.45	3.92M	Oct 7, 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	-$230K	-18K	-0.45%	$12.77	3.97M	Oct 12, 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	-$140K	-10.9K	-0.27%	$12.83	3.96M	Oct 13, 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	-$273K	-21.1K	-0.54%	$12.90	3.87M	Oct 14, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

John Simard, CEO Chairman of XBiotech, Inc., adopted a stock trading plan. He sold total of 89,286 common stock on the open market as part of this 10B5-1 trading plan.